Key regions: United Kingdom, India, Canada, Germany, China
The Vitamins & Minerals (Pharmacies) market in Niger has seen significant growth in recent years, driven by changing customer preferences and local special circumstances. Customer preferences in the market have shifted towards a greater focus on health and wellness. As consumers become more health-conscious, there has been an increased demand for vitamins and minerals to supplement their diets and support their overall well-being. This trend is not unique to Niger, but is reflective of a global shift towards preventive healthcare and self-care. In addition to changing customer preferences, there are also local special circumstances that have contributed to the growth of the Vitamins & Minerals (Pharmacies) market in Niger. The country has a high prevalence of malnutrition, particularly among children and pregnant women. As a result, there is a greater need for nutritional supplements to address these deficiencies. The government and non-profit organizations have also implemented programs to promote the use of vitamins and minerals as a means to combat malnutrition. The Vitamins & Minerals (Pharmacies) market in Niger is also influenced by underlying macroeconomic factors. The country has experienced steady economic growth in recent years, leading to an increase in disposable income. As a result, consumers have more purchasing power and are able to afford nutritional supplements. Additionally, the government has implemented policies to improve access to healthcare, including the availability of vitamins and minerals in pharmacies. Overall, the Vitamins & Minerals (Pharmacies) market in Niger is developing in response to changing customer preferences, local special circumstances, and underlying macroeconomic factors. As consumers become more health-conscious and the government continues to address malnutrition, the demand for vitamins and minerals is expected to continue to grow. Additionally, as the economy continues to improve and access to healthcare expands, the market is likely to see further development.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
